menotropins and Cerebrovascular-Disorders

We describe 15 malpractice claims that were filed after the patients had strokes. Both embolic and thrombotic, sterile and infected strokes led to claims. Ten of the claims alleged physician failure to protect the patient, two alleged physician failure to react as called for by symptoms, and three were related to medication. We conclude that physicians should advise patients of the possibility of stroke when circumstances warrant it, as well as documenting their judgment and suggested preventive practices. These cases further suggest that treatment decisions supported by documented second opinions may reduce the number of malpractice claims for strokes.

Topics: Anti-Bacterial Agents; Anticoagulants; Bacterial Infections; Cerebrovascular Disorders; Clinical Protocols; Decision Making; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Endocarditis, Bacterial; Female; Fertility Agents, Female; Headache; Humans; Hypoglycemia; Intracranial Embolism and Thrombosis; Ischemic Attack, Transient; Judgment; Male; Malpractice; Medical Records; Menotropins; Patient Education as Topic; Physician-Patient Relations; Referral and Consultation; Risk Factors; Vasculitis

Cerebral infarction due to menotropin therapy without evidence of ovarian hyperstimulation is presented. The patient was successfully treated with aspirin and anticonvulsive agents and was discharged without residual neurologic symptoms.

Topics: Adult; Cerebrovascular Disorders; Clomiphene; Female; Humans; Menotropins; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Tomography, X-Ray Computed